Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

HON, HRC, PWRM, MTL - Market Update From DrStockPick.com!

drstock-2-3

signup3m


power3

Power3 Medical Products, Inc. (OTC.BB:PWRM) is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig’s disease).

Worldwide, breast cancer consists 10.4% in all cancer occurrence among women, rendering it the most common form of non-skin cancer in females and the fifth most typical reason for cancer death. In ‘04, breast cancers triggered 519,000 fatalities across the world (7% associated with cancer deaths; practically 1% of all deaths). Breast cancer is roughly a hundred times more established in females compared to men, despite the fact that males are apt to have poorer successes on account of waiting times in a diagnosis.

Parkinson’s disease typically has effects on people around fifty. The early signs of PD tend to be subtle and also occur gradually. When it comes to many people the condition moves along more rapidly than in others. The fact that the condition moves along, the shaking, or tremor, which will has an effect on nearly all PD individuals may turn to restrict every day actions.

Other signs and symptoms may include depression and other emotional changes; difficulty in swallowing, chewing, and speaking; urinary problems or constipation; skin problems; and sleep disruptions. There are currently no blood or laboratory tests that have been which can support in diagnosing sporadic PD. For that reason the medical diagnosis is determined by track record and a neurological examination. The illness can be tough to diagnose precisely.

************************************************

Mechel OAO (NYSE:MTL) announced on December 13, 2010, the launch of its U.S.-based subsidiary Mechel Bluestone’s newest coal processing plant for washing coal mined at the Keystone Operations near Keystone, West Virginia.The K2 plant, worth 12 million dollars in investments, can process annually up to 3 million tonnes of run-of-mine coal. Annual production volume at the first stage is expected to exceed 1 million tonnes. The plant can efficiently recover high-quality low-volatile coking coal from high reject material common to thin-seam mining operations.The launch will allow Mechel Bluestone to double its production of low-volatile coking coal.

Mechel OAO, through its subsidiaries, operates as a mining and steel company in the Russian Federation and internationally. The company operates in four segments: Mining, Steel, Ferroalloys, and Power. The Mining segment produces coking and steam coal, as well as iron ore and iron ore concentrate. This segment operates four open pit mines and three underground coal mines in the Kuznetsky Basin, near the city of Mezhdurechensk in southwestern Siberia.

************************************************

Hill-Rom Holdings, Inc. (NYSE:HRC) announced that it has bought out the minority interest of its Encompass TSS joint venture with Encompass Group.Encompass TSS, LLC was formed a little over a year ago to focus on the sale and distribution of a comprehensive range of surface replacement systems, combining Hill-Rom’s strengths in therapy surface innovation and Encompass’ highly regarded family of AccuMax® and MaxiFloat® surfaces. Over the past year, Encompass TSS has made excellent progress in realizing its vision of rapidly penetrating the growing surface replacement segment. The buy-out will allow Hill-Rom to better align its sales channels and fully integrate Encompass TSS products and services, enhancing Hill-Rom’s customer experience.

Hill-Rom Holdings, Inc. provides medical technologies and related services for the health care industry in the United States and internationally. It provides patient support systems, non-invasive therapeutic products for acute and chronic medical conditions, medical equipment rentals, safe mobility and handling solutions, and information technology solutions. The company's patient support systems include various electrically adjustable and manual bed systems, and integrated and non integrated therapeutic surfaces for use in high, mid, and low acuity settings; multiple surface/mattress offerings; and surgical accessories.

************************************************

Honeywell International Inc. (NYSE:HON) announced on December 10, 2010 that its Board of Directors has approved a 10% increase, or $0.12 per common share, in the company’s regular annual cash dividend rate to $1.33 from $1.21 per common share, effective with the first quarter 2011 dividend payment. The actual declaration of any future dividends and the establishment of the record dates related thereto remains subject to further action by Honeywell’s Board.

Honeywell International Inc. operates as a diversified technology and manufacturing company worldwide. Its Aerospace segment provides turbine propulsion engines, auxiliary power units, environmental control systems, electric power systems, engine systems and accessories, avionics systems, aircraft and obstruction lighting systems, inertial sensor systems, control products, space products and subsystems, management and technical services, and landing systems for aircraft manufacturers, airlines, business and general aviation, military, space, and airport operations.

**************************************************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

drstbc

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://drstockpick.com/disclaimer) .Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (OTCPK:CRWE) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (OTC:PWRM).